Cover Image

Correction to “Mind and skin: Exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitis”

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Allergy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The skin microbiome in pediatric atopic dermatitis and food allergy
by: Elizabeth Huiwen Tham, et al.
Published: (2024)

Neonatal skin dysbiosis to infantile atopic dermatitis: Mitigating effects of skin care
by: Reika Aoyama, et al.
Published: (2024)

Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years
by: Emma Guttman‐Yassky, et al.
Published: (2024)

Algorithms in allergy: Diagnosis and management of atopic dermatitis in adulthood
by: M. Grace Hren, et al.
Published: (2024)

Ocular surface disease in pediatric patients with moderate‐to‐severe atopic dermatitis
by: Lisa P. van der Rijst, et al.
Published: (2025)

Bidirectional associations between IgE ‐mediated food allergy and atopic dermatitis
by: C. Venter, et al.
Published: (2024)

Association between telomere length and atopic dermatitis among school‐age children
by: Hsin‐Yi Huang, et al.
Published: (2025)

Use of dupilumab for atopic dermatitis in pediatric and young adult patients with inborn errors of immunity
by: Paola Zangari, et al.
Published: (2024)

Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy
by: Roselie Achten, et al.
Published: (2024)

Impact of climate change on atopic dermatitis: A review by the International Eczema Council
by: Sheng‐Pei Wang, et al.
Published: (2024)

T cell immunophenotypes and IgE responses in patients with moderate‐to‐severe atopic dermatitis receiving dupilumab
by: Davender Redhu, et al.
Published: (2025)

Correction to Water hardness and atopic dermatitis in the first year of life in the New Hampshire Birth Cohort Study
Published: (2025)

Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration
by: Claudia Traidl‐Hoffmann, et al.
Published: (2024)

Skin and gut microbiome in atopic dermatitis: Mechanisms and therapeutic opportunities
by: Binbin Hou, et al.
Published: (2025)

Eosinophilia, atopic dermatitis, and dupilumab: A potentially dangerous liaison?
by: Yung‐Yi Lan, et al.
Published: (2026)

Evolution of pathologic B‐cell subsets and serum environment‐specific sIgEs in patients with atopic dermatitis and controls, from infancy to adulthood
by: Tali Czarnowicki, et al.
Published: (2024)

Is there a direct link between skin barrier dysfunction and asthma?
by: Alexandra F. Santos
Published: (2024)

Expression of concern: The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double‐blinded, placebo‐controlled trial
Published: (2024)

Dupilumab induces a significant decrease of food specific immunoglobulin E levels in pediatric atopic dermatitis patients
by: Lisa P. van der Rijst, et al.
Published: (2024)

Trajectories of childhood atopic dermatitis and their association with attention‐deficit hyperactivity disorder
by: Yunxuan Zhang, et al.
Published: (2025)

Propionate alleviates itch in murine models of atopic dermatitis by modulating sensory TRP channels of dorsal root ganglion
by: Yao Xu, et al.
Published: (2024)

Distinct gut microbiome shifts in the NICU influence later atopic dermatitis development
by: Emily S. Robbins, et al.
Published: (2025)

Fecal microbiota transplantation against moderate‐to‐severe atopic dermatitis: A randomized, double‐blind controlled explorer trial
by: Xiaochun Liu, et al.
Published: (2024)

SCCA2 as a biomarker reflecting patient‐reported disease burden in children with mild atopic dermatitis under maintenance therapy
by: Yasuaki Yasuda, et al.
Published: (2026)

Ruxolitinib cream improves outcomes in atopic dermatitis: An updated systematic review and meta‐analysis
by: Laura Ghanem, et al.
Published: (2026)

Genome‐wide cross‐trait analysis of heterogeneous outcomes in early life atopic dermatitis
by: Lisa J. Martin, et al.
Published: (2025)

20 years of the socioeconomic impact of atopic dermatitis and alopecia areata from around the globe
by: Katarina Stevanovic, et al.
Published: (2025)

SM17, a new IL‐17RB‐targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis
by: Lik Hang Lam, et al.
Published: (2024)

Relationship of advanced glycation end products with disease severity in breast‐fed infants with atopic dermatitis
by: Şenay Burçin Alkan, et al.
Published: (2024)

Trends in atopic dermatitis prevalence among the Chinese population (1990–2021) with projections for 2022–2030
by: Jingjing Zhou, et al.
Published: (2024)

Associations between dietary patterns, gut microbiome diversity, and itch severity in preschool aged children with atopic dermatitis: A cross‐sectional study
by: Jisu Park, et al.
Published: (2025)

Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild‐to‐moderate atopic dermatitis: A randomized, double‐blind, vehicle‐controlled trial
by: Min Seo Kim, et al.
Published: (2024)

Early exposure to maternal stress and risk for atopic dermatitis in children: A systematic review and meta‐analysis
by: Yuan Ai, et al.
Published: (2024)

Residential greenness and atopic dermatitis in Japanese children: Findings from the TMM BirThree cohort study
by: Ami Uematsu, et al.
Published: (2026)

Emulsion containing a chitosan derivative in children with mild atopic dermatitis: A randomized controlled trial
by: Nagatoshi Sagara, et al.
Published: (2025)

Dibutyl phthalate induces atopic dermatitis via semaphorin‐plexin signaling and IL‐5: ECHO‐COCOA study
by: Mi‐Jin Kang, et al.
Published: (2025)

A microarray‐based IgE‐molecular mimicry index (IgE‐MMI): A biomarker for disease severity, clinical phenotypes, and therapeutic response in atopic dermatitis?
by: Enrico Scala, et al.
Published: (2024)

Higher prevalence of dupilumab‐induced ocular adverse events in atopic dermatitis compared to asthma: A daily practice analysis
by: Anne R. Schlösser, et al.
Published: (2024)

Maternal first‐trimester serum vitamin A/E concentration and risk of infant atopic dermatitis within 12 months
by: Ying Ye, et al.
Published: (2025)

Comparative efficacy of biologics and small molecule drugs in treating pediatric atopic dermatitis in patients aged 2–18 years: A 12–16 week network meta‐analysis of randomized controlled trials
by: Su‐Boon Yong, et al.
Published: (2025)